Results 101 to 110 of about 22,517 (214)
Prophylactic octreotide for pancreatoduodenectomy: more harm than good?
BACKGROUND Most accrued evidence regarding prophylactic octreotide for a pancreatoduodenectomy (PD) predates the advent of the International Study Group of Pancreatic Fistula (ISGPF) classification system for a post-operative pancreatic fistula (POPF ...
M. McMillan+8 more
semanticscholar +1 more source
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding.
Kocfa Chung-Delgado+4 more
doaj +1 more source
OCTREOTIDE IN GASTROENTEROLOGY [PDF]
Balwinder Singh+2 more
openaire +3 more sources
Management of massive upper gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide--a report of five cases. [PDF]
S A Jenkins+5 more
openalex +1 more source
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
The anti-tumoral activity of somatostatin has been demonstrated in both animal experiments and human tumors. Clinical trials have reported conflicting results.
Maria Georgiadou+6 more
doaj +1 more source
Chronic intestinal pseudoobstruction (CIPO) is a serious complication in patients with connective tissue disease (CTD) and is sometimes life-threatening or fatal despite intensive medical treatment. Here, we report a patient with dermatomyositis (DM) and
Chiho Yamada+8 more
doaj +1 more source
Aim. To study the relationship between the clinical course of myocardial infarction (MI) with changes in left ventricular (LV) geometry and myocardial accumulation of the somatostatin analogue 99mTc-octreotide according to cardiac single-photon emission ...
V. V. Ryabov+5 more
doaj +1 more source
Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreotide [PDF]
Giovanni Lupoli+6 more
openalex +1 more source